Policy Development

Reducing the growing burden of liver disease and its social and economic impact in APAC

What We Do

We raise awareness of the burden of liver diseases in the APAC region

And highlight the value that better liver disease prevention and control can bring to the APAC region.

We are advocates calling for better response and commitment

We push for political commitment in APAC to facilitate sustainable access for patients for liver disease care.

We provide evidence based guidance to policy makers

This contributes positively to improving equitable access and better liver health outcomes in APAC which in turns benefit both health systems and society.

Almost two-thirds of global deaths due to liver disease occurred in the Asia-Pacific region*

APAC Liver Disease Deaths, Globally

Causes of liver-related deaths in the Asia-Pacific region

Cirrhosis 48%
Liver Cancer 44%
Acute Viral Hepatitis 8%

HCC 3rd leading cause of cancer deaths

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide, with an increasing mortality rate in many countries.

*Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission

Cirrhosis is mainly caused by HBV, HCV, alcohol consumption and NAFLD
: hepatitis B virus, HCV: hepatitis C virus, NAFLD: non-alcoholic fatty liver disease

Making it a Priority for Decision-Makers

Liver disease should be a priority for decision-makers in health systems in the APAC region.

Our AllianceWhat We Do

A new platform is needed to look at the entire continuum of liver diseases.

This would help to:
Create a Credible Platform

Create an official, neutral platform for policy discussions and campaigns on liver diseases and health.

Lead Initiatives

Lead more coordinated and coherent advocacy activities.

Demonstrate the Urgency

Demonstrate the true burden of liver diseases as well as the true costs for the patients, providers, healthcare systems, governments and economies.

Speak with One Voice

Maximise impact through multilateral alliance engagement and speaking with one collective voice.

Generate Evidence

Generate evidence that supports policy-making and implementation.

Campaign for better liver care.
Promote knowledge, research
and international collaboration.

Join us in reducing the burden of liver diseases in the Asia-Pacific region.


We work closely with our members in our research and advocacy initiatives.

Dr Huma Qureshi

Consultant Gastroenterologist and National Lead on the Prevention and Control of Viral Hepatitis, Pakistan

Prof Yuen Man Fung

Chair Professor of Gastroenterology and Hepatology, Department of Medicine, The University of Hong Kong

Prof Masatoshi Kudo, MD, PhD

Professor and Chairman at the Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine

We are proud members of the Coalition for Global Hepatitis Elimination (CGHE)